Valuation Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2025-12-05 EST			5-day change	1st Jan Change
121.22 ^USD	-1.14%		-3.67%	+31.23%

12-03	Soleno Therapeutics, Inc. Announces Demise of William G. Harris, Member of Board of Directors and Audit Committee Changes	CI
12-03	Gilead Sciences, Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:50 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	73,031	91,081	107,677	100,942	115,118	150,395	-	-
Change	-	24.72%	18.22%	-6.25%	14.04%	30.64%	-	-
Enterprise Value (EV) ¹	103,910	118,530	126,522	118,665	131,838	163,112	156,508	150,749
Change	-	14.07%	6.74%	-6.21%	11.1%	23.72%	-4.05%	-3.68%
P/E ratio	583x	14.7x	23.6x	18x	243x	17.7x	16.2x	15x
PBR	4.04x	4.32x	5.05x	4.48x	5.98x	6.63x	5.53x	4.69x
PEG	-	0x	-0.9x	0.8x	-2.7x	0x	1.74x	1.92x
Capitalization / Revenue	2.96x	3.34x	3.95x	3.72x	4x	5.15x	5x	4.77x
EV / Revenue	4.21x	4.34x	4.64x	4.38x	4.59x	5.58x	5.2x	4.78x
EV / EBITDA	7.88x	8.12x	8.86x	9.01x	11.7x	10.2x	9.46x	8.74x
EV / EBIT	8.88x	9.45x	10.4x	11.3x	15.5x	12.3x	11.1x	10.1x
EV / FCF	13.8x	11x	15.2x	16x	12.8x	15.1x	12.4x	11.4x
FCF Yield	7.24%	9.12%	6.59%	6.25%	7.82%	6.6%	8.09%	8.75%
Dividend per Share ²	2.72	2.84	2.92	3	3.08	3.308	3.458	3.605
Rate of return	4.67%	3.91%	3.4%	3.7%	3.33%	2.73%	2.85%	2.97%
EPS ²	0.1	4.93	3.64	4.5	0.38	6.855	7.494	8.078
Distribution rate	2,720%	57.6%	80.2%	66.7%	811%	48.3%	46.1%	44.6%
Net sales ¹	24,689	27,305	27,281	27,116	28,754	29,208	30,082	31,540
EBITDA ¹	13,184	14,598	14,283	13,177	11,287	15,976	16,551	17,258
EBIT ¹	11,704	12,548	12,180	10,484	8,520	13,286	14,075	14,991
Net income ¹	123	6,225	4,592	5,665	480	8,282	8,943	9,633
Net Debt ¹	30,879	27,449	18,845	17,723	16,720	12,716	6,113	354.1
Reference price ²	58.26	72.61	85.85	81.01	92.37	121.22	121.22	121.22
Nbr of stocks (in thousands)	1,253,528	1,254,384	1,254,244	1,246,042	1,246,266	1,240,680	-	-
Announcement Date	2/4/21	2/1/22	2/2/23	2/6/24	2/11/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GILEAD SCIENCES, INC.	17.68x	5.58x	10.21x	2.73%	150B
ELI LILLY AND COMPANY	44.17x	14.63x	32.47x	0.59%	905B
JOHNSON & JOHNSON	19.27x	5.41x	14.97x	2.56%	487B
ABBVIE INC.	52.81x	7.48x	17.71x	2.89%	400B
ROCHE HOLDING AG	18.03x	4.54x	11.37x	3.18%	330B
ASTRAZENECA PLC	27.29x	5.16x	15.31x	1.78%	281B
NOVARTIS AG	18.36x	4.97x	11.67x	3.07%	255B
MERCK & CO., INC.	12.89x	4.21x	9x	3.24%	248B
NOVO NORDISK A/S	13.42x	4.8x	9.94x	3.76%	214B
AMGEN INC.	25.21x	6.12x	10.51x	2.9%	178B
Average	24.91x	6.29x	14.32x	2.67%	344.69B
Weighted average by Cap.	29.57x	7.85x	18.14x	2.26%